These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 17133164)
1. The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Mahomed H; Kibel M; Hawkridge T; Schaaf HS; Hanekom WA; Iloni K; Michaels D; Workman L; Verver S; Geiter L; Hussey GD Pediatr Infect Dis J; 2006 Dec; 25(12):1167-72. PubMed ID: 17133164 [TBL] [Abstract][Full Text] [Related]
2. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383 [TBL] [Abstract][Full Text] [Related]
3. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland. Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831 [TBL] [Abstract][Full Text] [Related]
4. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800 [TBL] [Abstract][Full Text] [Related]
5. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Hesseling AC; Cotton MF; Jennings T; Whitelaw A; Johnson LF; Eley B; Roux P; Godfrey-Faussett P; Schaaf HS Clin Infect Dis; 2009 Jan; 48(1):108-14. PubMed ID: 19049436 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262 [TBL] [Abstract][Full Text] [Related]
7. Age-related tuberculosis incidence and severity in children under 5 years of age in Cape Town, South Africa. Moyo S; Verver S; Mahomed H; Hawkridge A; Kibel M; Hatherill M; Tameris M; Geldenhuys H; Hanekom W; Hussey G Int J Tuberc Lung Dis; 2010 Feb; 14(2):149-54. PubMed ID: 20074404 [TBL] [Abstract][Full Text] [Related]
8. The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study. Fack C; Wood R; Hatherill M; Cobelens F; Hermans S Vaccine; 2022 Jan; 40(2):364-369. PubMed ID: 34872798 [TBL] [Abstract][Full Text] [Related]
9. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989. Romanus V; Svensson A; Hallander HO Tuber Lung Dis; 1992 Jun; 73(3):150-61. PubMed ID: 1421348 [TBL] [Abstract][Full Text] [Related]
10. Surgical complications of bacille Calmette-Guérin (BCG) infection in HIV-infected children: time for a change in policy. Karpelowsky JS; Alexander AG; Peek SD; Millar AJ; Rode H S Afr Med J; 2008 Oct; 98(10):801-4. PubMed ID: 19115758 [TBL] [Abstract][Full Text] [Related]
11. Childhood tuberculosis and tuberculous meningitis: high incidence rates in the Western Cape of South Africa. Berman S; Kibel MA; Fourie PB; Strebel PM Tuber Lung Dis; 1992 Dec; 73(6):349-55. PubMed ID: 1292715 [TBL] [Abstract][Full Text] [Related]
15. Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings. Manissero D; Lopalco PL; Levy-Bruhl D; Ciofi Degli Atti ML; Giesecke J Vaccine; 2008 Apr; 26(18):2253-9. PubMed ID: 18400344 [TBL] [Abstract][Full Text] [Related]
16. Tuberculosis case finding for vaccine trials in young children in high-incidence settings: a randomised trial. Moyo S; Verver S; Hawkridge A; Geiter L; Hatherill M; Workman L; Ontong C; Msemburi W; Tameris M; Geldenhuys H; Mulenga H; Snowden MA; Hanekom WA; Hussey G; Mahomed H; Int J Tuberc Lung Dis; 2012 Feb; 16(2):185-91. PubMed ID: 22236918 [TBL] [Abstract][Full Text] [Related]
17. Bovine TB and the development of new vaccines. Hope JC; Villarreal-Ramos B Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):77-100. PubMed ID: 17764740 [TBL] [Abstract][Full Text] [Related]
18. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis. Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065 [TBL] [Abstract][Full Text] [Related]
19. Determining causes of mortality in children enrolled in a vaccine field trial in a rural area in the Western Cape Province of South Africa. Moyo S; Hawkridge T; Mahomed H; Workman L; Minnies D; Geiter LJ; Verver S; Kibel M; Hussey GD J Paediatr Child Health; 2007 Mar; 43(3):178-83. PubMed ID: 17316193 [TBL] [Abstract][Full Text] [Related]
20. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment. Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]